Pay in 4 interest-free payments of $6.92 Learn more
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5
However, whether p53 is a bona fide substrate of COP1 in vivo is still a topic of ongoing debate 25,26,27,31
Electrophoresis Instrumentation Vertical Gel Electrophoresis Horizontal Gel Electrophoresis Blotting Instruments Isoelectric Focusing 2-D Gel Electrophoresis Power Supplies Gel Stainers Proteomics Proteomics Reagents Proteomics Instrumentation Laboratory Equipment Centrifuges Dry Block Heaters & Cooling Instruments Microplate Shakers PCR UV Cabinet Water Baths and Chillers General Purpose Water Baths Shaking Water Baths Heated Recirculating Water Baths Refrigerated Water Baths and Chillers Boiling Water Baths High Temperature OIl Baths Rockers and Rotators Shakers and Vortex Mixers Spectrophotometers & Densitometers ThermoShakers Electrophoresis Gels & Reagents SDS-PAGE mini-Gels IEF Horizontal Gels IEF Vertical Precast Gels IPG Strips Ampholytes Buffers Dyes & Stains Acrylamides & Agaroses Gel Supports & Membranes Markers Protein Stardard Markers Nucleic Acid Stardard Markers Reagents Biochemicals Biochemicals A Z Polyethylene Glycols Enzymes Enzymes A - Z Coenzymes, Cofactors, Nucleotides Enzyme & Protease Inhibitors Enzyme Substrates Buffering Compounds Collagenase Neutral Protease Ion Exchange Media Ion Exchange Resins Polymeric Adsorbent Beads Chelating Resins CM & DEAE Ion Exchange Media Sample Preparation and Quantification Kits Sample Preparation Kits Protein Quantification Kits Albumins About Us Orders, Returns and Cancelations 70-18-8 l-glutathione 23150 23150.03 23150.04 Description Product Details Reviews (0) L-Glutathione (reduced form) by SERVA Electrophoresis Research grade L-glutathione, CAS 70-18-8 Form: Crystaline (GSH, -L-Glutamyl-L-cysteinylglycine) C 10 H 17 N 3 O 6 S M r 307.3 Assay (CE)
10.1530/JOE-12-0143 140 StrmerE
The dosing protocol is five injections per week into an area of subcutaneous fat, such as an arm, a thigh, or your belly
CagriSema submitted for FDA approval in December 2025 with expected approval in Q4 2026 or Q1 2027, meaning launch around mid-2027
US$ 20.32
US$ 21.23
US$ 29.17
US$ 20.06
US$ 20.58
